LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis



Status:Recruiting
Conditions:Orthopedic, Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:25 - 80
Updated:2/9/2019
Start Date:July 17, 2017
End Date:December 2023

Use our guide to learn which trials are right for you!

A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis

The LimiFlex™ Clinical Trial is a prospective, concurrently controlled, multi-center study to
evaluate the safety and effectiveness of decompression and stabilization with the Empirical
Spine LimiFlex™ Paraspinous Tension Band compared to decompression and transforaminal lumbar
interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) for the treatment of
lumbar degenerative spondylolisthesis (Grade I per Meyerding classification) with spinal
stenosis. Clinical trial sites will enroll solely LimiFlex subjects or solely TLIF/PLF
subjects.

The LimiFlex™ Paraspinous Tension Band is a new stabilization option for patients being
treated with surgical decompression for degenerative spondylolisthesis. The LimiFlex does not
require pedicle screws to anchor to the spine; instead, two dynamic rods are attached by
screws to pedicle-sparing straps which encircle adjacent spinous processes.

Inclusion Criteria (patients must meet ALL of the following criteria to be eligible for
participation in the study):

1. Lumbar degenerative spondylolisthesis (Grade I per Meyerding classification), at one
level from L1 to S1, with radiographic confirmation using X-ray;

a. Grade I spondylolisthesis per Meyerding classification includes up to 25% anterior
translation of a vertebra relative to the superior endplate of the subjacent vertebra
at the index level. A patient is considered to have spondylolisthesis with a minimum
10% anterolisthesis at the affected level in a lateral x-ray image.

2. Lumbar spinal stenosis, at the level diagnosed with degenerative spondylolisthesis,
and confirmed radiographically using CT or MRI;

a. At the index level, lumbar spinal stenosis is at least moderate lumbar canal
stenosis, defined as more than 25% reduction of the cross-sectional area compared with
the next adjacent normal level, with nerve root crowding compared with the normal
level, as determined by the investigator on CT Scan or MRI.

3. Neurogenic claudication or radiculopathic symptoms including leg pain, muscle
weakness, and/or sensation abnormality, with or without back pain as evidenced by
patient history;

4. Persistent symptoms despite at least 6 months of conservative treatment that may
include but is not limited to physical therapy, medications, and/or epidural
injections;

5. A pre-operative Visual Analog Scale (VAS) leg pain score of ≥50 on a 100 mm scale;

6. A pre-operative Oswestry Disability Index (ODI) score ≥35 points on a 100-point scale;

7. Candidate for surgical decompression and stabilization at only one level between
L1-S1;

8. Posterior element anatomy is appropriate for interspinous fixation including
prediction of presence of spinous processes of segment to be instrumented following
decompression (investigational AND control groups) and a prediction of >50% of facet
joints present following decompression (investigational group only);

9. 25-80 years of age and skeletally mature;

10. Patient has the necessary mental capacity to participate and is willing and able to
participate in the study for the duration of the study follow-up and is able to comply
with study requirements; and

11. Patient is willing to provide Informed Consent for study participation.

Exclusion Criteria:

1. A primary and predominate diagnosis of discogenic back pain;

2. A primary and predominate diagnosis of facet-mediated back pain;

3. Back or non-radicular leg pain of unknown etiology;

4. Significant peripheral vascular disease causing vascular claudication;

5. Significant peripheral neuropathy caused by conditions other than spinal stenosis;

6. History of fixed or permanent neurological deficit related to spinal cord injury;

7. History of any previous surgery* at any level in the lumbosacral spine except for a
discectomy or decompression;

8. History of any previous surgery* at the level planned for treatment;

- previous surgery includes spinal stimulator placement but does NOT include
epidural injections

9. Isthmic spondylolisthesis or spondylolysis (pars fracture) at any level in the lumbar
spine;

10. Clinically significant compromise of vertebrae at L1 to S1 levels due to osteoporotic
vertebral compression fracture or any traumatic, neoplastic, metabolic or infectious
pathology or congenital abnormality;

11. Spinous process fracture(s) or other posterior element fracture(s) of the segment to
be instrumented;

12. Spinous process insufficiency or deformity that would preclude secure fixation of the
LimiFlex Device to the spinous process including spinous process length <10 mm from
lamina to dorsal tip or other significant deformity due to trauma, or congenital
abnormality such as spina bifida occulta at the planned instrumented level;

13. The estimated distance between the LimiFlex Device strap attachment points (midpoint
of the cranial edge of the cranial spinous process and the midpoint of the caudal edge
of the caudal spinous process) is <30mm on pre-operative lateral standing radiographs
at the segment to be instrumented;

14. Degenerative lumbar scoliosis with a Cobb angle >10° at the affected motion segment;

15. Symptomatic lumbar stenosis that is not amenable to a direct decompression

16. Anklyosed motion segment at the target operative level

17. Severe osteoporosis, defined as history of fragility fracture and DXA T-score <-2.5 or
QCT T-score < -2.5. History of a fragility fracture requires that a DXA scan or QCT
scan is completed;

18. Planned hip or knee replacement surgery;

19. Documented allergy to titanium or polyethylene;

20. Active local or systemic infection;

21. Receiving immunosuppressive or long-term steroid therapy;

22. Known history of bone metabolic disorder, including Paget's disease,
hyperparathyroidism, renal osteodystrophy, and osteomalacia;

23. Disease or condition that would preclude accurate clinical evaluation of the safety
and effectiveness of the study treatment or any significant medical conditions which
would place the patient at excessive risk for surgery, such as:

1. severe rheumatoid arthritis or other autoimmune disease

2. active hepatitis (viral or serum) or HIV positive

3. unstable cardiac disease

4. uncontrolled diabetes

5. renal failure

6. severe muscular, neural or vascular diseases that endanger the spinal column

7. cauda equina syndrome

8. severe neurologic disorders including paralysis

9. systemic lupus erythematosus;

24. Morbid obesity defined as BMI >40;

25. History of malignancy within the last five years;

26. Women who are pregnant or are interested in becoming pregnant within the study period;

27. Currently seeking or receiving worker's compensation for back pain or spinal
condition;

28. Currently involved in spinal litigation that potentially is associated with secondary
financial gain;

29. Current involvement in a study of another investigational product for similar purpose;

30. Demonstrates three or more Waddell's Signs of Inorganic Behavior;

31. Active treatment of a major psychiatric condition, such as major depression, anxiety
disorder, bipolar disorder, schizophrenia, personality disorder, that could prevent
accurate completion of self reporting assessment scales;

32. Current history (within 12 months) of substance abuse, including alcohol abuse; or

33. A prisoner.
We found this trial at
21
sites
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Principal Investigator: Timothy Yoon, MD
Phone: 404-778-6857
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Phone: 617-667-1172
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Binghamton, New York 13903
Phone: 607-240-2379
?
mi
from
Binghamton, NY
Click here to add this to my saved trials
Boston, Massachusetts 01805
Phone: 781-744-8774
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boulder, Colorado 80303
Principal Investigator: Alan Villavicencio, MD
Phone: 303-938-5700
?
mi
from
Boulder, CO
Click here to add this to my saved trials
Carmel, Indiana 46032
Principal Investigator: Rick Sasso, MD
Phone: 317-715-5897
?
mi
from
Carmel, IN
Click here to add this to my saved trials
Chicago, Illinois 60612
Phone: 312-563-1025
?
mi
from
Chicago, IL
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Principal Investigator: Elizabeth Yu, MD
Phone: 614-293-6131
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
2315 Stockton Boulevard
Davis, California 95817
Phone: 916-734-4980
?
mi
from
Davis, CA
Click here to add this to my saved trials
535 E 70th St
New York, New York 10021
(212) 606-1000
Phone: 917-260-4694
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
?
mi
from
New York, NY
Click here to add this to my saved trials
2000 Broadway
Oakland, California 94612
Phone: 510-891-5955
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: William Welch, MD
Phone: 215-829-6700
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Roseville, California 95661
Phone: 916-973-5714
?
mi
from
Roseville, CA
Click here to add this to my saved trials
Royal Oak, Michigan 48073
Principal Investigator: Jeffery Fischgrund, MD
Phone: 248-551-6679
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
San Jose, California 95119
Phone: 408-972-6735
?
mi
from
San Jose, CA
Click here to add this to my saved trials
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
5300 Tallman Ave NW
Seattle, Washington 98122
(206) 782-2700
Phone: 206-215-2843
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
300 Pasteur Dr
Stanford, California 94305
(650) 723-4000
Principal Investigator: Ivan Cheng, MD
Phone: 650-721-7600
Stanford Univ Med Ctr The Medical Center is uniquely advantaged by its location on the...
?
mi
from
Stanford, CA
Click here to add this to my saved trials
750 East Adams Street
Syracuse, New York 13210
Principal Investigator: William Lavelle, MD
Phone: 315-464-8618
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Tampa, Florida 33607
Phone: 813-392-7435
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Tempe, Arizona 85281
Phone: 602-443-4169
?
mi
from
Tempe, AZ
Click here to add this to my saved trials